Mark J. Vignola Terns Pharmaceuticals, Inc. (TERN) insider trading activity

Mark J. Vignola is Chief Financial Officer of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 91,940 shares of TERN, which is worth approximately $538,768. The most recent transaction as insider was on Sep 10, 2024, when has been sold 10,000 shares (Common Stock) at a price of $11.0 per share, resulting in proceeds of $110,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 91.9K

0% 3M change

399.7% 12M change

Total Value Held $538,768

Mark J. Vignola Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2024	SELL Open market or private sale	$110,000 $11.0 p/Share	10,000 Reduced 9.81%	91,940 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	$53,600 $5.36 p/Share	10,000 Added 8.93%	101,940 Common Stock
May 31 2024	BUY Open market or private purchase	$21,272 $4.44 p/Share	4,791 Added 4.95%	91,940 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	68,750 Added 44.1%	87,149 Common Stock
Nov 30 2023	BUY Open market or private purchase	$2,808 $3.78 p/Share	743 Added 3.88%	18,399 Common Stock
May 31 2023	BUY Open market or private purchase	$14,095 $1.41 p/Share	9,997 Added 36.15%	17,656 Common Stock
Nov 30 2022	BUY Open market or private purchase	$4 $1.41 p/Share	3 Added 0.04%	7,659 Common Stock
May 31 2022	BUY Open market or private purchase	$11,254 $1.47 p/Share	7,656 Added 50.0%	7,656 Common Stock

MJV

Mark J. Vignola

Chief Financial Officer

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Value

Insider Trading

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Terns Pharmaceuticals, Inc.

Track Activities on TERN

Account